{"title":"Harnessing nanotechnology for improved drug delivery across the blood-brain barrier and enhanced neural repair","authors":"Miaomiao Xu, Heng Wang, Chengchen Wang, Chu Wang, Shenghao Hu, Lixing Weng","doi":"10.1016/j.ijpharm.2025.126221","DOIUrl":null,"url":null,"abstract":"<div><div>The blood–brain barrier (BBB) serves as the primary interface between the bloodstream and the brain, maintaining the delicate balance and homeostasis crucial for the proper functioning of the central nervous system (CNS). However, the BBB’s selective permeability poses significant challenges for drug delivery, hindering the treatment of CNS-related diseases. In recent years, advancements in technology have revolutionized approaches to drug delivery across the BBB, yet few nanomaterials have achieved success in clinical trials. In this review, we first examine the structure and function of the BBB, followed by an analysis of the mechanisms by how drugs can penetrate it. We then focus on strategies that leverage nanomaterials to facilitate BBB crossing, categorizing these materials based on their compositions. Additionally, we specifically highlight recent advances in the development of nanomedicines from nanomaterials for the treatment of various CNS diseases and summarize nanomaterials that have been tested in clinical trials for nerve repair. Finally, we provide a perspective on future directions in this field.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"685 ","pages":"Article 126221"},"PeriodicalIF":5.2000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325010580","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The blood–brain barrier (BBB) serves as the primary interface between the bloodstream and the brain, maintaining the delicate balance and homeostasis crucial for the proper functioning of the central nervous system (CNS). However, the BBB’s selective permeability poses significant challenges for drug delivery, hindering the treatment of CNS-related diseases. In recent years, advancements in technology have revolutionized approaches to drug delivery across the BBB, yet few nanomaterials have achieved success in clinical trials. In this review, we first examine the structure and function of the BBB, followed by an analysis of the mechanisms by how drugs can penetrate it. We then focus on strategies that leverage nanomaterials to facilitate BBB crossing, categorizing these materials based on their compositions. Additionally, we specifically highlight recent advances in the development of nanomedicines from nanomaterials for the treatment of various CNS diseases and summarize nanomaterials that have been tested in clinical trials for nerve repair. Finally, we provide a perspective on future directions in this field.
期刊介绍:
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.